Pacira BioSciences' Enterprise Value rose 279.19% to $911.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$512.5 million, marking a year-over-year increase of 33.29%. This contributed to the annual value of $385.3 million for FY2024, which is 70.09% down from last year.
Pacira BioSciences' Enterprise Value amounted to $911.6 million in Q3 2025, which was up 37.95% from $660.8 million recorded in Q2 2025.
In the past 5 years, Pacira BioSciences' Enterprise Value ranged from a high of $3.0 billion in Q1 2022 and a low of $240.4 million during Q3 2024.
In the last 3 years, Pacira BioSciences' Enterprise Value had a median value of $927.5 million in 2024 and averaged $965.0 million.
In the last 5 years, Pacira BioSciences' Enterprise Value tumbled by 79.78% in 2024 and then soared by 279.19% in 2025.
Pacira BioSciences' Enterprise Value (Quarterly) stood at $2.0 billion in 2021, then dropped by 26.73% to $1.5 billion in 2022, then dropped by 13.13% to $1.3 billion in 2023, then slumped by 70.09% to $385.3 million in 2024, then surged by 279.19% to $911.6 million in 2025.
Its Enterprise Value was $911.6 million in Q3 2025, compared to $660.8 million in Q2 2025 and $656.3 million in Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value